Magenta Therapeutics, Inc. Gains 51.66%
Fri, Feb 03, 2023 at 07:07 PM
Magenta Therapeutics, Inc. (MGTA:NASDAQ) shot up at $0.86, a gain of 51.7%. On Fri, Feb 03, 2023, MGTA:NASDAQ touched a New 2-Week High of $0.86. The stock appeared on our News Catalysts scanner on Wed, Jan 25, 2023 at 04:32 PM in the 'BIOTECH' category. From Fri, Jan 20, 2023, the stock recorded 60.00% Up Days and 63.64% Green Days
About Magenta Therapeutics, Inc. (MGTA:NASDAQ)
Magenta Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing novel medicines to bring the curative power of bone marrow transplant.
Top 10 Gainers:
- Heart Test Laboratories, Inc. (HSCS:NASDAQ), 139.44%
- Genetic Technologies Limited (GENE:NASDAQ), 82%
- Guardforce AI Co. Limited (GFAI:NASDAQ), 76%
- AlerisLife Inc. (ALR:NASDAQ), 60.53%
- Magenta Therapeutics, Inc. (MGTA:NASDAQ), 51.66%
- SpringBig Holdings Inc. (SBIG:NASDAQ), 47.3%
- BigBear.ai Inc. (BBAI:NYSE), 44.17%
- SoundHound AI Inc. (SOUN:NASDAQ), 43.88%
- Metalpha Technology Holding Ltd Shs (MATH:NASDAQ), 39.34%
- Check-Cap Ltd. (CHEK:NASDAQ), 32.81%